Related Experiment Video
Updated: Mar 25, 2026

5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats
Published on: April 4, 2025
Challenges and opportunities for stem cell therapy in patients with chronic kidney disease
LaTonya J Hickson1, Alfonso Eirin1, Lilach O Lerman1
1Division of Nephrology and Hypertension, Mayo Clinic, Rochester, Minnesota, USA.
Insights
Regenerative cell therapies show promise for chronic kidney disease (CKD). However, factors in CKD patients may impair stem cell function, necessitating methods to enhance cell vitality for effective treatment.
Area of Science:
- Nephrology
- Regenerative Medicine
- Cell Biology
Background:
- Chronic kidney disease (CKD) is a significant global health issue with limited effective treatments.
- The kidney's regenerative capacity is poor, driving the need for novel therapeutic approaches like cell-based therapies.
- Autologous cell transplantation is preferred for CKD to avoid allosensitization, but requires verified cell function.
Purpose of the Study:
- To review current knowledge on stem and progenitor cell function in the context of CKD.
- To identify barriers within the uremic environment that may compromise cell-based therapies.
- To explore novel strategies for improving stem cell function for potential CKD transplantation.
Main Methods:
- Literature review of studies on stem and progenitor cells in regenerative medicine.
- Analysis of factors contributing to reduced cell function in CKD patients (age, comorbidities, uremia).
- Examination of paracrine and differentiation mechanisms of endothelial progenitor cells and mesenchymal stem cells.
Main Results:
- Endothelial progenitor cells and mesenchymal stem cells offer therapeutic potential via paracrine effects (angiogenesis, anti-inflammation, antifibrosis).
- CKD-specific factors like uremia, inflammation, and comorbidities can significantly impair autologous stem cell function and vitality.
- Existing knowledge highlights challenges in achieving therapeutic efficacy with current autologous cell-based approaches for CKD.
Conclusions:
- Stem and progenitor cells hold promise for CKD treatment, but their effectiveness is challenged by the uremic milieu.
- Further research is needed to develop methods that enhance stem cell function and overcome barriers in CKD patients.
- Optimizing cell vitality and function is crucial for the successful clinical application of regenerative cell therapies in chronic kidney disease.
Abstract:
Chronic kidney disease (CKD) is a global health care burden affecting billions of individuals worldwide. The kidney has limited regenerative capacity from chronic insults, and for the most common causes of CKD, no effective treatment exists to prevent progression to end-stage kidney failure. Therefore, novel interventions, such as regenerative cell-based therapies, need to be developed for CKD. Given the risk of allosensitization, autologous transplantation of cells to boost regenerative potential is preferred. Therefore, verification of cell function and vitality in CKD patients is imperative. Two cell types have been most commonly applied in regenerative medicine. Endothelial progenitor cells contribute to neovasculogenesis primarily through paracrine angiogenic activity and partly by differentiation into mature endothelial cells in situ. Mesenchymal stem cells also exert paracrine effects, including proangiogenic, anti-inflammatory, and antifibrotic activity. However, in CKD, multiple factors may contribute to reduced cell function, including older age, coexisting cardiovascular disease, diabetes, chronic inflammatory states, and uremia, which may limit the effectiveness of an autologous cell-based therapy approach. This Review highlights current knowledge on stem and progenitor cell function and vitality, aspects of the uremic milieu that may serve as a barrier to therapy, and novel methods to improve stem cell function for potential transplantation.
Related Concept Videos
Chronic Kidney Disease III: Interprofessional Care
Chronic Kidney Disease I: Introduction
Kidney Transplant I: Introduction
Stem Cell Therapy for Tissue Regeneration
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
Chronic Kidney Disease II: Clinical Manifestations
Chronic Kidney Disease IV: Nursing Management

